Home/Filings/4/0001127602-18-025370
4//SEC Filing

MARCHIO ALBERT N II 4

Accession 0001127602-18-025370

CIK 0001472091other

Filed

Aug 14, 8:00 PM ET

Accepted

Aug 15, 7:59 AM ET

Size

5.3 KB

Accession

0001127602-18-025370

Insider Transaction Report

Form 4
Period: 2018-08-14
MARCHIO ALBERT N II
Chief Acct. & Op., Asst. Sec.
Transactions
  • Award

    Restricted Stock Units

    2018-08-14+41,66641,666 total
    Common Stock (41,666 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
  • [F2]These options shall become exercisable upon the achievement of certain performance or time based criteria.
  • [F3]Expiration date is not applicable as the vested Restricted Stock Units shall be settled on the first business day following the date that such Restricted Stock Units vest.

Issuer

Edge Therapeutics, Inc.

CIK 0001472091

Entity typeother

Related Parties

1
  • filerCIK 0001196054

Filing Metadata

Form type
4
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 7:59 AM ET
Size
5.3 KB